TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
JNJ

Johnson & Johnson

Healthcare · Drug Manufacturers - General

269.20$ -0.1% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow JNJ
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
24.8% 27.5% 26.1% 27.5% 27.2% 28.5% 28.5% 29.7% 26.5% 26.8% 27.3% 26.0%
5.2% 5.3% 5.2% 7.4% 8.5% 8.5% 8.8% 9.4% 8.7% 8.8% 8.3% 8.0%
1.1% 1.2% 1.2% 1.3% 1.2% 1.2% 1.2% 1.4% 1.4% 1.4% 1.3% 1.4%
-1.0% -1.9% 0.3% 3.8% 0.0% -3.1% -1.3% -0.8% 0.4%
-1.4% 1.9% -2.5% 14.7% 0.0% 4.7% 3.3% -5.4% -5.0% 2.9% 2.1% -13.5%
5.0% 4.9% 4.5% 4.3% 4.5% 4.3% 4.1% 4.6% 5.0% 5.3% 5.0% 5.1%
-16.6% -11.0% -6.6% -19.4% -3.9% -7.5% -25.2% -11.0% -15.5% 1.0% -20.9% -25.0%
10.5% 11.7% 12.0% 11.7% 11.6% 12.1% 12.7% 14.0% 14.6% 13.8% 13.3% 13.1%
-9.6% -7.5% -12.5% -8.3% -7.2% -8.2% -3.9% -4.4% -7.5% -5.9% -2.7% -6.3%
1.1% 2.0% 11.0% 8.8% -4.8% -3.5% 8.6% -1.3% 9.3% -3.2% 11.3% 10.2%
-16.5% -15.5% -11.9% -10.0% -22.7% -22.0% -7.4% -17.8% -11.1% -18.6% -3.5% -5.9%
-8.6% -1.1% 7.3% -1.5% 0.3% -1.0% -4.0% 0.6% -0.5% 9.1% 2.5% -4.7%
19.9% 22.6% 21.6% 23.3% 22.7% 24.3% 24.4% 25.1% 21.5% 21.4% 22.3% 20.9%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?